| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratories of Tumor Cell Biology [R. C. G.] and Pathology [E. J., J. C.] and NCI-Navy Medical Oncology [P. A. B.], Environmental Epidemiology [D. W. B., W. B.], Metabolism [S. B.], and Medicine [R. I. F.] Branches, National Cancer Institute, Bethesda, Maryland 20205; Department of Cell Biology, Litton Bionetics, Inc., Kensington, Maryland 20895 [V. S. K., M. G. S., A. S., M. R-G.]; Skin and Cancer Hospital, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140 [E. C. V.]; Chest Disease Research Institute [M. M.] and Department of Microbiology, Faculty of Medicine [Y. I.], Kyoto University, Kyoto, Japan; Department of Medicine, Kobe University School of Medicine, Kobe, Japan [Y. N.]; Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan [K. Y.]; Department of Epidemiology, Harvard University School of Public Health, Boston, Massachusetts 02115 [N. G.]; St. Jude Children's Research Hospital, Memphis, Tennessee 38101 [S. M.]; M.R.C. Leukaemia Unit, Royal Postgraduate Medical School [D. C.], and Membrane Immunology Laboratory, Imperial Cancer Research Fund Laboratories [M. F. G.], London, England; Department of Veterinary Pathology, University of Glasgow, Glasgow, Scotland [W. F. H. J.]; Klinikum der Albert-Ludwigs-Universität, Institut für Virologie im Zentrum für Hygiene, Freiburg, Germany [H. z. H.]; Bátiment INSERM, Hopital Saint-Louis, Paris, France [M. S., J. C. B.]; Duke University Medical Center, Durham 27710 [B. F. H.], and VA Medical Center, Durham 27705 [B. V. J.], North Carolina; and Department of Medicine, University of California at Los Angeles, Los Angeles, California 90024 [D. W. G.]
To determine whether the human T-cell lymphoma-leukemia virus (HTLV) is associated with particular cancers, patient sera were surveyed for HTLV-specific antibodies. An association was seen with aggressive cancers of mature T-cells, specifically Japanese adult T-cell leukemia (ATL) and T-cell lymphosarcoma cell leukemia (TLCL), a similar cancer of Caribbean blacks. Ninety to 100% of these patients possessed HTLV-specific antibody. Forty-seven and 20% of relatives of ATL and TLCL patients, respectively, and 12 and 4% of healthy donors from ATL and TLCL endemic areas were also antibody positive. Visceral organ involvement, hypercalcemia, and skin manifestation, features of ATL and TLCL, were often seen in other antibody-positive patients. Childhood cancers, most cutaneous T-cell and all non-T-cell leukemias and lymphomas, myeloid leukemias, Hodgkin's disease, and solid tumors were not associated with HTLV. Healthy United States donors and European patients with nonmalignant diseases were antibody negative. HTLV is thus associated with a subtype of adult T-cell leukemia-lymphoma, clustered in viral endemic areas, with apparent racial and geographic predilection.
1 To whom requests for reprints should be addressed.
Received 2/23/83. Accepted 4/22/83.
This article has been cited by other articles:
![]() |
S. L. Tarsis, M.-T. Yu, E. S. Parks, D. Persaud, J. L. Munoz, and W. P. Parks Human T-Lymphocyte Transformation with Human T-Cell Lymphotropic Virus Type 2 J. Virol., January 1, 1998; 72(1): 841 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Grossman and L. Ratner Cytokine Expression and Tumorigenicity of Large Granular Lymphocytic Leukemia Cells From Mice Transgenic for the tax Gene of Human T-Cell Leukemia Virus Type I Blood, July 15, 1997; 90(2): 783 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hall, C. Liu, O Schneewind, H Takahashi, M. Kaplan, G Roupe, and A Vahlne Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides Science, July 19, 1991; 253(5017): 317 - 320. [Abstract] [PDF] |
||||
![]() |
K. A. Foon, K. R. Rai, and R. P. Gale Chronic Lymphocytic Leukemia: New Insights into Biology and Therapy Ann Intern Med, October 1, 1990; 113(7): 525 - 539. [Abstract] [PDF] |
||||
![]() |
W. A. Blattner Human T-Lymphotrophic Viruses and Diseases of Long Latency Ann Intern Med, July 1, 1989; 111(1): 4 - 6. [Abstract] [PDF] |
||||
![]() |
A. Williams, C. Fang, D. Slamon, B. Poiesz, S. Sandler, W. Darr 2nd, G Shulman, E. McGowan, D. Douglas, R. Bowman, et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors Science, April 29, 1988; 240(4852): 643 - 646. [Abstract] [PDF] |
||||
![]() |
W Wachsman, A. Cann, J. Williams, D. Slamon, L Souza, N. Shah, and I. Chen HTLV x gene mutants exhibit novel transcriptional regulatory phenotypes Science, February 6, 1987; 235(4789): 674 - 677. [Abstract] [PDF] |
||||
![]() |
I. Chen, A. Cann, N. Shah, and R. Gaynor Functional relation between HTLV-II x and adenovirus E1A proteins in transcriptional activation Science, November 1, 1985; 230(4725): 570 - 573. [Abstract] [PDF] |
||||
![]() |
I. Chen, D. Slamon, J. Rosenblatt, N. Shah, S. Quan, and W Wachsman The x gene is essential for HTLV replication Science, July 5, 1985; 229(4708): 54 - 58. [Abstract] [PDF] |
||||
![]() |
R. P. GALE and K. A. FOON Chronic Lymphocytic Leukemia: Recent Advances in Biology and Treatment Ann Intern Med, July 1, 1985; 103(1): 101 - 120. [Abstract] [PDF] |
||||
![]() |
K. Samuel, J. Lautenberger, C. Jorcyk, S Josephs, F Wong-Staal, and T. Papas Diagnostic potential for human malignancies of bacterially produced HTLV-I envelope protein Science, November 30, 1984; 226(4678): 1094 - 1097. [Abstract] [PDF] |
||||
![]() |
M Popovic, N Flomenberg, D. Volkman, D Mann, A. Fauci, B Dupont, and R. Gallo Alteration of T-cell functions by infection with HTLV-I or HTLV-II Science, October 26, 1984; 226(4673): 459 - 462. [Abstract] [PDF] |
||||
![]() |
T. Lee, J. Coligan, J. Sodroski, W. Haseltine, S. Salahuddin, F Wong-Staal, R. Gallo, and M Essex Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene Science, October 5, 1984; 226(4670): 57 - 61. [Abstract] [PDF] |
||||
![]() |
W Saxinger, W. Blattner, P. Levine, J Clark, R Biggar, M Hoh, J Moghissi, P Jacobs, L Wilson, R Jacobson, et al. Human T-cell leukemia virus (HTLV-I) antibodies in Africa Science, September 28, 1984; 225(4669): 1473 - 1476. [Abstract] [PDF] |
||||
![]() |
T Homma, P. Kanki, N. King Jr, R. Hunt, M. O'Connell, N. Letvin, M. Daniel, R. Desrosiers, C. Yang, and M Essex Lymphoma in macaques: association with virus of human T lymphotrophic family Science, August 17, 1984; 225(4663): 716 - 718. [Abstract] [PDF] |
||||
![]() |
V. Kalyanaraman, C. Cabradilla, J. Getchell, R Narayanan, E. Braff, J. Chermann, F Barre-Sinoussi, L Montagnier, T. Spira, J Kaplan, et al. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS Science, July 20, 1984; 225(4659): 321 - 323. [Abstract] [PDF] |
||||
![]() |
M Popovic, M. Sarngadharan, E Read, and R. Gallo Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Science, May 4, 1984; 224(4648): 497 - 500. [Abstract] [PDF] |
||||
![]() |
R. Gallo, S. Salahuddin, M Popovic, G. Shearer, M Kaplan, B. Haynes, T. Palker, R Redfield, J Oleske, B Safai, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS Science, May 4, 1984; 224(4648): 500 - 503. [Abstract] [PDF] |
||||
![]() |
M. Sarngadharan, M Popovic, L Bruch, J Schupbach, and R. Gallo Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS Science, May 4, 1984; 224(4648): 506 - 508. [Abstract] [PDF] |
||||
![]() |
S. BRODER, P. A. BUNN Jr., E. S. JAFFE, W. BLATTNER, R. C. GALLO, F. WONG-STAAL, T. A. WALDMANN, and V. T. DeVITA Jr. T-Cell Lymphoproliferative Syndrome Associated with Human T-Cell Leukemia/Lymphoma Virus Ann Intern Med, April 1, 1984; 100(4): 543 - 557. [Abstract] [PDF] |
||||
![]() |
H. Guo, F Wong-Stall, and R. Gallo Novel viral sequences related to human T-cell leukemia virus in T cells of a seropositive baboon Science, March 16, 1984; 223(4641): 1195 - 1197. [Abstract] [PDF] |
||||
![]() |
M Essex, M. McLane, T. Lee, N Tachibana, J. Mullins, J Kreiss, C. Kasper, M. Poon, A Landay, S. Stein, et al. Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs Science, September 9, 1983; 221(4615): 1061 - 1064. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |